4.7 Article

Bioinformatics-based analysis of the association between the A1-chimaerin (CHN1) gene and gastric cancer

Journal

BIOENGINEERED
Volume 12, Issue 1, Pages 2874-2889

Publisher

TAYLOR & FRANCIS INC
DOI: 10.1080/21655979.2021.1940621

Keywords

Gastric cancer; CHN1; biomarker; immune cell infiltration; methylation

Funding

  1. Youth Science and Technology Project of Suzhou [KJXW2019059]
  2. Suzhou Science and Technology Development Plan [SYSD2019006]
  3. National Nature Science Foundation of china [81973782]

Ask authors/readers for more resources

The study evaluated the expression of the CHN1 gene in gastric cancer tissue and cells, finding that high CHN1 levels were associated with poor survival rates and potentially involved in carcinogenic pathways. Additionally, CHN1 expression was correlated with immune cell infiltration and immunotherapeutic response, indicating its role in cancer progression and treatment.
Gastric cancer (GC) is one of the most common causes of cancer-related deaths worldwide and the identification of additional therapeutic targets and biomarkers has become vital. The A1-chimaerin (CHN1) gene encodes a ras-related protein that can be activated or inactivated by binding to GTP or GDP. The present study aimed to assess the expression of CHN1 in GC tissue and cells, to explore its relationship with GC progression, and to discover the potential mechanisms underlying these associations. The ONCOMINE database and The Cancer Genome Atlas (TCGA) were used to determine the transcriptional levels of CHN1 in GC. Western blot and immunohistochemistry were used for detecting protein expression. Correlations between CHN1 levels and the clinical outcomes of GC patients were examined using Kaplan-Meier and Cox regression analyses. Moreover, the CIBERSORT algorithm was used to estimate immune cell infiltration. In GC patients, CHN1 transcription and CHN1 protein expression were upregulated, and a high expression of CHN1 was remarkably linked to poor survival in GC patients. CHN1 expression was associated with immune infiltrates and this gene showed potential involvement in multiple cancer-related pathways. Furthermore, the expression of CHN1 was correlated with the immunotherapeutic response. Finally, our results indicated that the pro-carcinogenic role of CHN1 may involve DNA methylation. To our knowledge, this is the first report characterizing CHN1 expression in GC. Our results show that high CHN1 levels could be used as a clinical biomarker for poor prognosis and that CHN1 inhibitors may have potential as anti-cancer drugs.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available